Immediate complications after medical compared with surgical termination of pregnancy

Obstetrics and Gynecology

Volumn 114, Issue 4, 2009, Pages 795-804

  Niinimäki, Maarit ^a,b,c,d   Pouta, Anneli ^a,b,c,d   Bloigu, Aini ^a,b,c,d   Gissler, Mika ^a,b,c,d   Hemminki, Elina ^a,b,c,d   Suhonen, Satu ^a,b,c,d   Heikinheimo, Oskari ^a,b,c,d  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b Graduate School of Circumpolar Wellbeing   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; BLEEDING; CONTROLLED STUDY; COUNSELING; DEATH; DEEP VEIN THROMBOSIS; DEPRESSION; ENDOMETRITIS; FEMALE; FINLAND; FOLLOW UP; HUMAN; INCIDENCE; INCOMPLETE ABORTION; INFECTION; INTOXICATION; LACERATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MEDICAL ABORTION; MORBIDITY; PELVIC INFLAMMATORY DISEASE; POSTOPERATIVE COMPLICATION; PREGNANCY; PRIORITY JOURNAL; PSYCHIATRY; PSYCHOSIS; PYREXIA IDIOPATHICA; REGISTER; RISK FACTOR; SEPTICEMIA; SURGICAL ABORTION; THROMBOEMBOLISM; URINARY TRACT INFECTION; UTERINE CERVICITIS; UTERINE CERVIX DISEASE; UTERUS PERFORATION; WOUND INFECTION;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; ADULT; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; ODDS RATIO; PREGNANCY; REOPERATION; UTERINE HEMORRHAGE; VACUUM CURETTAGE; YOUNG ADULT;

EID: 70349655529     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181b5ccf9     Document Type: Article

References (34)

1. Finer B, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-96
2. Jones RK, Zolna MR, Henshaw SK, Finer LB. Abortion in the United States: incidence and access to services, 2005. Perspect Sex Reprod Health 2008;40:6-16.
3. National Institute for Health and Welfare: Induced abortions. Available at: http://www.stakes.fi/EN/tilastot/statisticsbytopic/ reprodution/abortions. htm. Retrieved February 5, 2009.
4. The National Board of Health and Welfare. Available at: http://www.socialstyrelsen.se/. Accessed February 5, 2009.
5. Department of Health. Available at: www.dh.gov.uk. Accessed February 5, 2009.
6. Zhou W, Nielsen GL, Moller M, Olsen J. Short-term complications after surgically induced abortions: a register-based study of 56 117 abortions. Acta Obstet Gynecol Scand 2002; 81:331-336
7. Say L, Kulier R, Gulmezoglu M, Campana A. Medical versus surgical methods for first trimester termination of pregnancy. The Cochrane Database of Systemic Reviews 2005, Issue 1. Art.No.:CD003037.DOI:DOI:10.1002/14651858.CD003037. pub2.
8. Rorbye C, Norgaard M, Nilas L. Medical versus surgical abortion efficacy, complications and leave of absence compared in a partly randomized study. Contraception 2004;70: 393-399
9. Ashok PW, Kidd A, Flett GM, Fitzmaurice A, Graham W, Templeton A. A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation. Hum Reprod 2002;17:92-98
10. Henshaw RC, Naji SA, Russell IT, Templeton AA. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. Hum Reprod 1994;9:2167-2172
11. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG 2002;109:1281-1289
12. Niinimaki M, Pouta A, Bloigu A, Gissler M, Hemminki E, Suhonen S, et al. Frequency and risk factors for repeat abortions after surgical compared with medical termination of pregnancy. Obstet Gynecol 2009;113:845-852
13. Finlex. http://www.finlex.fi/fi/laki/ajantasa/1970/19700239? search%5Btype%5D-pika&search%5Bpika%5D-raskau%2A. Retrieved January 21, 2009.
14. Finnish Gynecological Association's task force. Abortion. Duodecim 2001;117:2084-2094
15. National Institute for Health and Welfare: Institutional health care. Available at: http://www.stakes.fi/EN/tilastot/statisticsby topic/ healthservices/institutionlahealthcare.htm. Accessed January 27, 2009.
16. Statistics Finland. Available at: www.stat.fi. Accessed January 27, 2009.
17. World Health Organization. Available at: http://www.who.int/ classifications/icd/en/. Accessed January 27, 2009.
18. Nordic Centre for Classifications in Health Care. http://www. nordclass.uu.se/. Accessed January 27, 2009.
19. Induced abortion operations and their early sequelae. Joint study of the Royal College of General Practitioners and the Royal College of Obstetricians and Gynaecologists. J R Coll Gen Pract 1985;35:175-180
20. Gissler M, Berg C, Bouvier-Colle MH, Buekens P. Pregnancyassociated mortality after birth, spontaneous abortion, or induced abortion in Finland, 1987-2000. Am J Obstet Gynecol 2004;190:422-427
21. Deneux-Tharaux C, Berg C, Bouvier-Colle MH, Gissler M, Harper M, Nannini A, et al. Underreporting of pregnancyrelated mortality in the United States and Europe [published erratum appears in Obstet Gynecol 2005;107:209]. Obstet Gynecol 2005;106:684-692
22. Gissler M, Ulander VM, Hemminki E, Rasimus A. Declining induced abortion rate in Finland: data quality of the Finnish abortion register. Int J Epidemiol 1996;25:376-380
23. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338:1241-1247
24. Sitruk-Ware R. Mifepristone and misoprostol sequential regimen side effects, complications and safety. Contraception 2006;74:48-55.
25. Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998;13:2962-2965
26. Cameron ST, Glasier AF, Logan J, Benton L, Baird DT. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh. Br J Obstet Gynaecol 1996;103:1222-1229
27. Fischer M, Bhatnagar J, Guarner J, Reagan S, Hacker JK, Van Meter SH, et al. Fatal toxic shock syndrome associated with clostridium sordellii after medical abortion. N Engl J Med 2005;353:2352-2360
28. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ, 3rd. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population- based study. Ann Intern Med 2005;143:697-706.
29. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006;194:1311-1315
30. Gissler M, Berg C, Bouvier-Colle MH, Buekens P. Injury deaths, suicides and homicides associated with pregnancy, Finland 1987-2000. Eur J Public Health 2005;15:459-463
31. Henshaw R, Naji S, Russell I, Templeton A. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study. Acta Obstet Gynecol Scand 1994;73:812-818
32. Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000;62:297-303.
33. Allen RH, Westhoff C, De Nonno L, Fielding SL, Schaff EA. Curettage after mifepristone-induced abortion: frequency, timing, and indications. Obstet Gynecol 2001;98:101-106
34. Child TJ, Thomas J, Rees M, MacKenzie IZ. A comparative study of surgical and medical procedures: 932 pregnancy terminations up to 63 days gestation. Hum Reprod 2001;16: 67-71.